Iovance Biotherapeutics, Inc. (IOVA)

Iovance Biotherapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	132.47	115.69	114.89	231.73	78.23	67.33
Short-Term Investments	168.71	208.09	164.98	240.11	426.18	562.11
Cash & Short-Term Investments	301.18	323.78	279.87	471.85	504.41	629.44
Cash Growth	-26.99%	15.69%	-40.69%	-6.46%	-19.86%	104.97%
Receivables	59.94	69.34	0.15	-	-	-
Inventory	49.83	51.52	10.37	-	-	-
Prepaid Expenses	11.55	12.38	17.46	7.27	3.55	6.66
Total Current Assets	422.5	457.02	307.85	479.12	507.96	636.1
Property, Plant & Equipment	172.42	164.28	176.55	178.25	169.92	113.92
Long-Term Investments	-	-	-	-	91.59	-
Other Intangible Assets	296.25	282.4	229.26	-	-	-
Other Long-Term Assets	16.26	6.73	66.7	6.62	7.87	18.44
Total Assets	907.44	910.43	780.35	663.98	777.33	768.46
Accounts Payable	32	27.51	33.12	26.6	27.38	13.51
Accrued Expenses	78.05	75.19	66.97	45.79	51.91	30.73
Current Portion of Leases	7.07	12.9	7.78	12.59	5.06	6.28
Other Current Liabilities	11.03	6.75	2.44	6.51	4.86	4.34
Total Current Liabilities	129.16	122.34	110.31	91.49	89.2	54.87
Long-Term Debt	-	1	1	1	1	-
Long-Term Leases	45.1	44.37	67.09	71.86	65.47	45.38
Long-Term Deferred Tax Liabilities	34.7	32.32	17.35	-	-	-
Other Long-Term Liabilities	-	-	-	-	-	11.71
Total Liabilities	208.95	200.02	195.74	164.34	155.67	111.96
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	3,290	3,096	2,594	2,069	1,795	1,487
Retained Earnings	-2,612	-2,385	-2,012	-1,568	-1,172	-830.19
Comprehensive Income & Other	20.86	-1.05	2.53	-0.9	-0.6	0.02
Total Common Equity	698.49	710.4	584.61	499.64	621.66	656.49
Shareholders' Equity	698.49	710.41	584.61	499.64	621.66	656.5
Total Liabilities & Equity	907.44	910.43	780.35	663.98	777.33	768.46
Total Debt	53.17	58.26	75.86	85.45	71.53	51.66
Net Cash (Debt)	248.02	265.52	204.01	386.4	432.88	577.78
Net Cash Growth	-25.04%	30.15%	-47.20%	-10.74%	-25.08%	95.47%
Net Cash Per Share	0.78	0.92	0.87	2.43	2.82	4.18
Filing Date Shares Outstanding	361.85	327.88	279.31	224.24	157.17	146.98
Total Common Shares Outstanding	341.92	305.25	256.14	187.81	157	146.87
Working Capital	293.35	334.68	197.54	387.63	418.76	581.23
Book Value Per Share	2.04	2.33	2.28	2.66	3.96	4.47
Tangible Book Value	402.23	428	355.35	499.64	621.66	656.49
Tangible Book Value Per Share	1.18	1.40	1.39	2.66	3.96	4.47
Machinery	37.88	34.28	33.27	31.79	14.87	5.41
Construction In Progress	32.29	34.94	24.1	9.12	35.78	56.76
Leasehold Improvements	85.9	67.38	76.8	74.31	57.82	2.57

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q